Trial Profile
Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Apr 2019
Price :
$35
*
At a glance
- Drugs Cefalexin (Primary)
- Indications Bacterial infections; Wound infections
- Focus Therapeutic Use
- 10 Dec 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Dec 2009 Actual initiation date (August 2009) added as reported by ClinicalTrials.gov.